|
Pv-R CYVE 1 and 2 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Consolidation 1 and 2 Group C CNS Negative
Pipeline
Phase 2: 1
Top Sponsors
- New York Medical College1
Indications
- Hodgkin Lymphoma1
- Non-hodgkin Lymphoma1
- Cancer1
Birmingham, Alabama1 trial
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
University of Alabama
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.